Pneumococcal Vaccine Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the pneumococcal vaccine market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Pneumococcal Vaccine Market Now And By 2029?

The pneumococcal vaccine market has experienced strong growth in recent years. It is projected to expand from $8.94 billion in 2024 to $9.4 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.2%. The historical growth of this market can be attributed to factors such as the discovery of streptococcus pneumoniae, significant public health concern, early vaccination efforts, advancements in healthcare, and changes in vaccine policy.

The pneumococcal vaccine market is projected to experience robust expansion over the coming years. This market is anticipated to reach $11.9 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. Factors driving this growth during the forecast period include the evolution of pneumococcal strains, ongoing research and development efforts, evolving immunization priorities, broader vaccine access, and an aging global population. Key trends for the upcoming period encompass the creation of multivalent vaccines, widespread vaccination among at-risk populations, strategies to enhance vaccine efficacy, robust education and awareness initiatives, and a focus on infant immunization.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp

Which Long-Term Drivers Are Expected To Sustain The Pneumococcal Vaccine Market?

The rising occurrence of pneumococcal contamination is anticipated to fuel expansion within the pneumococcal vaccine market in the future. This type of contamination signifies any infection resulting from the bacteria Streptococcus pneumoniae or pneumococcus, including ailments like pneumonia, bloodstream infections, ear infections, and sinus infections. The pneumococcal vaccine works by prompting the body to generate antibodies combatting pneumococcal bacteria, thereby diminishing or eradicating disease-causing bacteria and their toxins to safeguard children, seniors, and individuals with compromised immune systems against various forms of pneumococcal infections. For example, data from January 2022, provided by the Center for Disease Control and Prevention, a US-based public health authority, indicates that Pneumococcal pneumonia leads to an approximate 150,000 hospitalizations annually in the United States, constituting as much as 30% of adult community-acquired pneumonia. Consequently, the growing frequency of pneumococcal contamination is a key impetus for the expansion of the pneumococcal vaccine market.

How Is The Pneumococcal Vaccine Market Classified By Different Segments?

The pneumococcal vaccine market covered in this report is segmented –

1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products

2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous

3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

4) By End User: Pediatrics, Adults

Subsegments:

1) By Prevnar 13: Pediatric Formulation, Adult Formulation

2) By Synflorix: Pediatric Formulation, Adult Formulation

3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes

4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines

What Current And Upcoming Trends Are Shaping The Pneumococcal Vaccine Market?

Leading companies operating in the pneumococcal vaccine market are introducing new products to enhance their profitability. For example, in July 2023, Merck & Co Inc., a US-based pharmaceuticals company, launched its V116 vaccine. V116 is designed to target the eight distinct serotypes of Streptococcus pneumoniae primarily responsible for adult pneumococcal disease. Compared to other pneumococcal vaccines, V116 exhibited superior immunogenicity for various serotypes in adult populations and generated positive immune responses in both vaccine-naïve and previously vaccinated individuals. The U.S. Food and Drug Administration (FDA) has recognized V116 as a breakthrough therapy, and it is currently undergoing Phase 3 development.

Who Are The Primary Market Leaders In The Pneumococcal Vaccine Market?

Major companies operating in the pneumococcal vaccine market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Astellas Pharma Inc., CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, Inventprise LLC, Tergene Biotech Private Limited, PnuVax Incorporated, SK Bioscience Co Ltd

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Pneumococcal Vaccine Market?

North America was the largest region in the pneumococcal vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=11950&type=smp

Browse Through More Reports Similar to the Global Pneumococcal Vaccine Market 2025, By The Business Research Company

Medical Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

Medical Waste Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-waste-management-global-market-report

Medical Tubing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795